News About: Pharm. Industry
Multinational firms urged to compensate returned goods
Despite the price cuts in January, six multinational drug manufactures decided not to compensate any returned goods sold before March, it was learned by an emergency council of the Korean Pharmaceutical Wholesaler Ass...
Pfizer Korea sales and profit rise in 2011
Pfizer Korea, Korean unit of Pfizer Inc., posted 452.6 billion won in revenue last year, although its operating profit dipped to 672 million won.
It net profit recorded a whopping 227.83 percent to 21.2 billion wo...
Interactions between certain HIV and cholesterol-lowering statin drugs can increase the risk of musc
The U.S. Food and Drug Administration (FDA) on March 1 issued its updated recommendations concerning drug-drug interactions between drugs for human immunodeficiency virus (HIV) known as protease inhibitors and certain...
Ilsung to file suit against government
A lawsuit seeking a court injunction for a senseless drug price policy by the Ministry of Health and Welfare will be filed today with a regional court in Seoul, a law firm dealing with the litigation for Ilsung Pharma...
Restructuring hitting pharmaceutical sector
Korea’s pharmaceutical sector is headed for a fresh round of restructuring, with many companies pushing employees to opt for early retirement plans amid growing worries over the lackluster earnings outlook.
Domesti...
Pre-operative treatment of uterine fibroids approved by European Commission, Shinpoong says
Shinpoong Pharmaceutical Co. says the European Commission (EC) has recently granted marketing authorization to Esmya (ulipristal acetate) 5mg tablets as pre-operative treatment of moderate to severe symptoms of uterin...
Daewoong to face biggest blow from price-cut plan
Daewoong Pharmaceutical Co. is likely to take a bigger blow from the government’s plan to slash drug prices starting April, Daeshin Securities said yesterday.
Daeshin said the loss of Daewoong’s sales is expected t...
Herceptin’s drug insurance claim ranks eighth in 2011
Roche’s Herceptin, a drug for treatment of breast cancer, ranked eighth in a list of 10 leading drugs claiming insurance reimbursement last year, Yakup.com said yesterday.
Citing the data released by the Health Ins...
Some leading companies under fire over passive attitude
Some of 20 leading drug firms have been criticized for their lukewarm attitude over legal action against the government’s plan to slash insurance drug prices in April.
These companies are said to take a suit agains...
Lee re-elected to head pharmaceutical trade group
Lee Dong-soo, chief executive of Pfizer Pharmaceuticals Korea Ltd., was re-elected the 11th chairman of the Korean Research-based Pharmaceutical Industry Association on Mar. 5, the association said.
Lee graduated ...
